Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > TXG 10x Genomics > Detailed Quotes

TXG 10x Genomics

31.350
-0.740-2.31%
Close 10/06 16:00 ET
High
32.550
Open
32.120
Turnover
20.16M
Low
30.555
Pre Close
32.090
Volume
645.13K
Market Cap
3.57B
P/E(TTM)
Loss
52wk High
187.850
Shares
113.91M
P/E(Static)
Loss
52wk Low
27.510
Float Cap
3.23B
Bid/Ask %
66.67%
Historical High
208.990
Shs Float
102.91M
Volume Ratio
0.55
Historical Low
27.510
Dividend TTM
--
Div Yield TTM
--
P/B
4.56
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.63%
Amplitude
6.22%
Avg Price
31.248
Lot Size
1
Float Cap
3.23B
Bid/Ask %
66.67%
Historical High
208.990
Shs Float
102.91M
Volume Ratio
0.55
Historical Low
27.510
Dividend TTM
--
P/B
4.56
Dividend LFY
--
Turnover Ratio
0.63%
Amplitude
6.22%
Avg Price
31.248
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
CEO: Dr. Serge Saxonov, PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...